» Articles » PMID: 34680309

MiRNA-424-5p Suppresses Proliferation, Migration, and Invasion of Clear Cell Renal Cell Carcinoma and Attenuates Expression of O-GlcNAc-Transferase

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2021 Oct 23
PMID 34680309
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) are non-coding post-transcriptional regulators of gene expression that are dysregulated in clear cell renal cell carcinoma (ccRCC) and play an important role in tumor progression. Our prior work identified a subset of miRNAs in pT1 ccRCC tumors, including miR-424-5p, that are associated with an aggressive phenotype. We investigate the impact of this dysregulated miRNA and its protein target O-GlcNAc-transferase (OGT) to better understand the mechanisms behind aggressive stage I ccRCC. The ccRCC cell lines 786-O and Caki-1 were used to assess the impact of miR-424-5p and OGT. Cells were transfected with pre-miR-424-5p, a lentiviral anti-OGT shRNA, or were treated with the demethylating agent 5-Aza-2'-deoxycytidine. Cell proliferation was measured via MT cell viability assay. Cell migration and invasion were analyzed using Transwell assays. The expression of miR-424-5p was determined through qRT-PCR, while OGT protein expression was evaluated through Western blotting. The interaction between miR-424-5p and OGT was confirmed via luciferase reporter assay. The transfection of ccRCC cells with pre-miR-424-5p or anti-OGT shRNA significantly inhibited cell proliferation, migration, and OGT expression, while miR-424-5p also attenuated cell invasion. Addition of the demethylating agent significantly reduced cell proliferation, migration, invasion, and OGT expression, while significantly increasing the expression of miR-424-5p. Altogether, these findings suggest that epigenetic downregulation of miR-424-5p, which in turn augments OGT expression, contributes to the creation of aggressive forms of stage I ccRCC.

Citing Articles

miRNA changes associated with differentiation of human embryonic stem cells into human retinal ganglion cells.

Esmaeili M, Smith D, Mead B Sci Rep. 2024; 14(1):31895.

PMID: 39738601 PMC: 11685716. DOI: 10.1038/s41598-024-83381-9.


MiR-424-5p Inhibits Proliferation, Migration, Invasion and Angiogenesis of the HTR-8/SVneo Cells Through Targeting LRP6 Mediated β-catenin.

Fei K, Zhang H, Zhang W, Liao C Reprod Sci. 2024; 31(11):3428-3439.

PMID: 38997540 DOI: 10.1007/s43032-024-01641-5.


Differentiation of Adipose Tissue Mesenchymal Stem Cells into Endothelial Cells Depends on Fat Depot Conditions: Regulation by miRNA.

Arderiu G, Civit-Urgell A, Diez-Caballero A, Moscatiello F, Ballesta C, Badimon L Cells. 2024; 13(6.

PMID: 38534357 PMC: 10969675. DOI: 10.3390/cells13060513.


Regulation of protein O-GlcNAcylation by circadian, metabolic, and cellular signals.

Liu X, Cai Y, Chiu J J Biol Chem. 2023; 300(2):105616.

PMID: 38159854 PMC: 10810748. DOI: 10.1016/j.jbc.2023.105616.


MEF2C and miR-194-5p: New Players in Triple Negative Breast Cancer Tumorigenesis.

Caetano S, Garcia A, Figueira I, Brito M Int J Mol Sci. 2023; 24(18).

PMID: 37762600 PMC: 10531597. DOI: 10.3390/ijms241814297.


References
1.
Hsieh J, Purdue M, Signoretti S, Swanton C, Albiges L, Schmidinger M . Renal cell carcinoma. Nat Rev Dis Primers. 2017; 3:17009. PMC: 5936048. DOI: 10.1038/nrdp.2017.9. View

2.
Li Q, Qiu X, Li Q, Wang X, Li L, Xu M . MicroRNA-424 may function as a tumor suppressor in endometrial carcinoma cells by targeting E2F7. Oncol Rep. 2015; 33(5):2354-60. DOI: 10.3892/or.2015.3812. View

3.
Trinca G, Goodman M, Papachristou E, DSantos C, Chalise P, Madan R . O-GlcNAc-Dependent Regulation of Progesterone Receptor Function in Breast Cancer. Horm Cancer. 2017; 9(1):12-21. PMC: 5775912. DOI: 10.1007/s12672-017-0310-9. View

4.
Slaby O, Redova M, Poprach A, Nekvindova J, Iliev R, Radova L . Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients. Genes Chromosomes Cancer. 2012; 51(7):707-16. DOI: 10.1002/gcc.21957. View

5.
Roche J . The Epithelial-to-Mesenchymal Transition in Cancer. Cancers (Basel). 2018; 10(2). PMC: 5836084. DOI: 10.3390/cancers10020052. View